CD73-dependent generation of adenosine and endothelial adora2b signaling attenuate diabetic nephropathy

Journal of the American Society of Nephrology

Volumn 25, Issue 3, 2014, Pages 547-563

  Tak, Eunyoung ^a   Ridyard, Douglas ^a   Kim, Jae Hwan ^a,b   Zimmerman, Michael ^a   Werner, Tilmann ^c   Wang, Xiaoxin X ^a,d   Shabeka, Uladzimir ^a   Seo, Seong Wook ^a   Christians, Uwe ^a   Klawitter, Jost ^a   Moldovan, Radu ^a   Garcia, Gabriela ^a   Levi, Moshe ^a,d   Haase, Volker ^e   Ravid, Katya ^f   Eltzschig, Holger K ^a   Grenz, Almut ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Korea University College of Medicine   (South Korea)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2B RECEPTOR; BAY 606583; NUCLEOTIDASE; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE SEVERITY; DRUG EFFICACY; EXTRACELLULAR MATRIX; FEMALE; GENE DELETION; GENE EXPRESSION; KIDNEY; KIDNEY TUBULE EPITHELIUM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RENAL PROTECTION; REPORTER GENE; SIGNAL TRANSDUCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TISSUE SPECIFICITY; VASCULAR ENDOTHELIUM;

5'-NUCLEOTIDASE; ADENOSINE; ANIMALS; DIABETIC NEPHROPATHIES; ENDOTHELIUM; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, ADENOSINE A2B;

EID: 84896854379     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012101014     Document Type: Article

References (78)

1. Eltzschig HK, Carmeliet P: Hypoxia and inflammation. N Engl J Med 364: 656-665, 2011
2. Eltzschig HK, Eckle T: Ischemia and reperfusion - from mechanism to translation. Nat Med 17: 1391-1401, 2011
3. Eltzschig HK: Adenosine: An old drug newly discovered. Anesthesiology 111: 904-915, 2009
4. Chen JF, Eltzschig HK, Fredholm BB: Adenosine receptors as drug targets - what are the challenges? Nat Rev Drug Discov 12: 265-286, 2013
5. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE: Cell death. N Engl J Med 361: 1570-1583, 2009
6. Chekeni FB, Elliott MR, Sandilos JK, Walk SF, Kinchen JM, Lazarowski ER, Armstrong AJ, Penuela S, Laird DW, Salvesen GS, Isakson BE, Bayliss DA, Ravichandran KS: Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis. Nature 467: 863-867, 2010
7. Faigle M, Seessle J, Zug S, El Kasmi KC, Eltzschig HK: ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia. PLoS ONE 3: e2801, 2008
8. Eltzschig HK, Eckle T, Mager A, Küper N, Karcher C, Weissmüller T, Boengler K, Schulz R, Robson SC, Colgan SP: ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ Res 99: 1100-1108, 2006 (Pubitemid 44729934)
9. Eckle T, Koeppen M, Eltzschig HK: Role of extracellular adenosine in acute lung injury. Physiology (Bethesda) 24: 298-306, 2009
10. Hart ML, Gorzolla IC, Schittenhelm J, Robson SC, Eltzschig HK: SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning. J Immunol 184: 4017-4024, 2010
11. Eltzschig HK, Köhler D, Eckle T, Kong T, Robson SC, Colgan SP: Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood 113: 224-232, 2009
12. Eltzschig HK, Macmanus CF, Colgan SP: Neutrophils as sources of extracellular nucleotides: functional consequences at the vascular interface. Trends Cardiovasc Med 18: 103-107, 2008 (Pubitemid 351626607)
13. Thompson LF, Eltzschig HK, Ibla JC, Van De Wiele CJ, Resta R, Morote-Garcia JC, Colgan SP: Crucial role for ecto-59-nucleotidase (CD73) in vascular leakage during hypoxia. J Exp Med 200: 1395-1405, 2004 (Pubitemid 39657287)
14. Eltzschig HK, Thompson LF, Karhausen J, Cotta RJ, Ibla JC, Robson SC, Colgan SP: Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: Coordination by extracellular nucleotide metabolism. Blood 104: 3986-3992, 2004 (Pubitemid 39620148)
15. Eltzschig HK, Ibla JC, Furuta GT, Leonard MO, Jacobson KA, Enjyoji K, Robson SC, Colgan SP:Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: Role of ectonucleotidases and adenosine A2B receptors. J Exp Med 198: 783-796, 2003 (Pubitemid 37087777)
16. Synnestvedt K, Furuta GT, Comerford KM, Louis N, Karhausen J, Eltzschig HK, Hansen KR, Thompson LF, Colgan SP: Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 110: 993-1002, 2002
17. Hart ML, Grenz A, Gorzolla IC, Schittenhelm J, Dalton JH, Eltzschig HK: Hypoxia-inducible factor-1a-dependent protection from intestinal ischemia/reperfusion injury involves ecto-5′-nucleotidase (CD73) and the A2B adenosine receptor. J Immunol 186: 4367-4374, 2011
18. Hart ML, Henn M, Köhler D, Kloor D, Mittelbronn M, Gorzolla IC, Stahl GL, Eltzschig HK: Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury. FASEB J 22: 2784-2797, 2008
19. Hart ML, Köhler D, Eckle T, Kloor D, Stahl GL, Eltzschig HK: Direct treatment of mouse or human blood with soluble 5′-nucleotidase inhibits platelet aggregation. Arterioscler Thromb Vasc Biol 28: 1477-1483, 2008
20. Hart ML, Much C, Gorzolla IC, Schittenhelm J, Kloor D, Stahl GL, Eltzschig HK. Extracellular adenosine production by ecto-5′-nucleotidase protects during murine hepatic ischemic preconditioning. Gastroenterology 135:1739-1750 e1733, 2008
21. Day YJ, Huang L, Ye H, Li L, Linden J, Okusa MD: Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma. J Immunol 176: 3108-3114, 2006
22. Day YJ, Huang L, McDuffie MJ, Rosin DL, Ye H, Chen JF, Schwarzschild MA, Fink JS, Linden J, Okusa MD: Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells. J Clin Invest 112: 883-891, 2003 (Pubitemid 38063746)
23. Grenz A, Bauerle JD, Dalton JH, Ridyard D, Badulak A, Tak E, McNamee EN, Clambey E, Moldovan R, Reyes G, Klawitter J, Ambler K, Magee K, Christians U, Brodsky KS, Ravid K, Choi DS, Wen J, Lukashev D, Blackburn MR, Osswald H, Coe IR, Nürnberg B, Haase VH, Xia Y, Sitkovsky M, Eltzschig HK: Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. J Clin Invest 122: 693-710, 2012
24. Grenz A, Osswald H, Eckle T, Yang D, Zhang H, Tran ZV, Klingel K, Ravid K, Eltzschig HK: The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med 5: e137, 2008
25. Grenz A, Zhang H, Eckle T, Mittelbronn M, Wehrmann M, Köhle C, Kloor D, Thompson LF, Osswald H, Eltzschig HK: Protective role of ecto-5′-nucleotidase (CD73) in renal ischemia. J Am Soc Nephrol 18: 833-845, 2007 (Pubitemid 46434500)
26. Grenz A, Zhang H, Hermes M, Eckle T, Klingel K, Huang DY, Müller CE, Robson SC, Osswald H, Eltzschig HK: Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury. FASEB J 21: 2863-2873, 2007 (Pubitemid 47372753)
27. Lappas CM, Day YJ, Marshall MA, Engelhard VH, Linden J: Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. J Exp Med 203: 2639-2648, 2006 (Pubitemid 44833340)
28. Hart ML, Jacobi B, Schittenhelm J, Henn M, Eltzschig HK: Cutting Edge: A2B Adenosine receptor signaling provides potent protection during intestinal ischemia/reperfusion injury. J Immunol 182: 3965-3968, 2009
29. Eckle T, Hartmann K, Bonney S, Reithel S, Mittelbronn M, Walker LA, Lowes BD, Han J, Borchers CH, Buttrick PM, Kominsky DJ, Colgan SP, Eltzschig HK: Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nat Med 18: 774-782, 2012
30. Eckle T, Köhler D, Lehmann R, El Kasmi KC, Eltzschig HK: Hypoxia-inducible factor-1 is central to cardioprotection: A new paradigm for ischemic preconditioning. Circulation 118: 166-175, 2008
31. Eckle T, Krahn T, Grenz A, Köhler D, Mittelbronn M, Ledent C, Jacobson MA, Osswald H, Thompson LF, Unertl K, Eltzschig HK: Cardioprotection by ecto-5′-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115: 1581-1590, 2007 (Pubitemid 46648643)
32. Eltzschig HK, Bonney SK, Eckle T: Attenuating myocardial ischemia by targeting A2B adenosine receptors. Trends Mol Med 19: 345-354, 2013
33. Zhou Y, Schneider DJ, Morschl E, Song L, Pedroza M, Karmouty-Quintana H, Le T, Sun CX, Blackburn MR: Distinct roles for the A2B adenosine receptor in acute and chronic stages of bleomycin-induced lung injury. J Immunol 186: 1097-1106, 2011
34. Schingnitz U, Hartmann K, Macmanus CF, Eckle T, Zug S, Colgan SP, Eltzschig HK: Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury. J Immunol 184: 5271-5279, 2010
35. Reutershan J, Vollmer I, Stark S, Wagner R, Ngamsri KC, Eltzschig HK: Adenosine and inflammation: Cd39 and cd73 are critical mediators in lps-induced pmn trafficking into the lungs. FASEB J 23: 473-482, 2009
36. Eckle T, Füllbier L, Grenz A, Eltzschig HK: Usefulness of pressure-controlled ventilation at high inspiratory pressures to induce acute lung injury in mice. Am J Physiol Lung Cell Mol Physiol 295: L718-L724, 2008
37. Eckle T, Füllbier L, Wehrmann M, Khoury J, Mittelbronn M, Ibla J, Rosenberger P, Eltzschig HK: Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J Immunol 178: 8127-8137, 2007 (Pubitemid 46898085)
38. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS: Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348: 2285-2293, 2003 (Pubitemid 36638102)
39. Schernthaner G: Kidney disease in diabetology: lessons from 2008. Nephrol Dial Transplant 24: 396-399, 2009
40. Amin R, Widmer B, Prevost AT, Schwarze P, Cooper J, Edge J, Marcovecchio L, Neil A, Dalton RN, Dunger DB: Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: Prospective observational study. BMJ 336: 697-701, 2008 (Pubitemid 351481211)
41. Mauer M, Zinman B, Gardiner R, Suissa S, Sinaiko A, Strand T, Drummond K, Donnelly S, Goodyer P, Gubler MC, Klein R: Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med 361: 40-51, 2009
42. Blackburn MR: Too much of a good thing: adenosine overload in adenosine-deaminase-deficient mice. Trends Pharmacol Sci 24: 66-70, 2003
43. Grenz A, Zhang H, Weingart J, von Wietersheim S, Eckle T, Schnermann JB, Kohle C, Kloor D, Gleiter CH, Vallon V, Eltzschig HK, Osswald H. Lack of effect of extracellular adenosine generation and signalling on renal erythropoietin secretion during hypoxia. Am J Physiol Renal Physiol 293: F1501-F1511, 2007 (Pubitemid 350085985)
44. Nadarajah R, Milagres R, Dilauro M, Gutsol A, Xiao F, Zimpelmann J, Kennedy C, Wysocki J, Batlle D, Burns KD: Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice. Kidney Int 82: 292-303, 2012
45. Friedman DJ, Rennke HG, Csizmadia E, Enjyoji K, Robson SC: The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathy. Diabetes 56: 2371-2379, 2007 (Pubitemid 47358244)
46. Kanesaki Y, Suzuki D, Uehara G, Toyoda M, Katoh T, Sakai H, Watanabe T: Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy. Am J Kidney Dis 45: 288-294, 2005 (Pubitemid 40431054)
47. Yang D, Zhang Y, Nguyen HG, Koupenova M, Chauhan AK, Makitalo M, Jones MR, St Hilaire C, Seldin DC, Toselli P, Lamperti E, Schreiber BM, Gavras H, Wagner DD, Ravid K: The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest 116: 1913-1923, 2006 (Pubitemid 44033315)
48. Aherne CM, Kewley EM, Eltzschig HK. The resurgence of a2b adenosine receptor signaling. Biochim Biophys Acta 1808:1329-1339, 2011
49. Frick JS, MacManus CF, Scully M, Glover LE, Eltzschig HK, Colgan SP: Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis. J Immunol 182: 4957-4964, 2009
50. Eckle T, Faigle M, Grenz A, Laucher S, Thompson LF, Eltzschig HK: A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood 111: 2024-2035, 2008 (Pubitemid 351451513)
51. Eckle T, Grenz A, Laucher S, Eltzschig HK: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J Clin Invest 118: 3301-3315, 2008
52. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG, Karin M: NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453: 807-811, 2008 (Pubitemid 351793778)
53. Alva JA, Zovein AC, Monvoisin A, Murphy T, Salazar A, Harvey NL, Carmeliet P, Iruela-Arispe ML: Ve-cadherin-cre-recombinase transgenic mouse: A tool for lineage analysis and gene deletion in endothelial cells. Development Dynam 235: 759-767, 2006
54. Skuli N, Liu L, Runge A, Wang T, Yuan L, Patel S, Iruela-Arispe L, Simon MC, Keith B: Endothelial deletion of hypoxia-inducible factor-2alpha (HIF-2alpha) alters vascular function and tumor angiogenesis. Blood 114: 469-477, 2009
55. Skuli N, Majmundar AJ, Krock BL, Mesquita RC, Mathew LK, Quinn ZL, Runge A, Liu L, Kim MN, Liang J, Schenkel S, Yodh AG, Keith B, Simon MC: Endothelial HIF-2a regulates murine pathological angiogenesis and revascularization processes. J Clin Invest 122: 1427-1443, 2012
56. Awad AS, Huang L, Ye H, Duong ET, Bolton WK, Linden J, Okusa MD: Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy. Am J Physiol Renal Physiol 290: F828-F837, 2006 (Pubitemid 43724943)
57. Wallace KL, Linden J: Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease. Blood 116: 5010-5020, 2010
58. Day YJ, Marshall MA, Huang L, McDuffie MJ, Okusa MD, Linden J: Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction. Am J Physiol Gastrointest Liver Physiol 286: G285-G293, 2004 (Pubitemid 38134040)
59. Grenz A, Clambey E, Eltzschig HK: Hypoxia signaling during intestinal ischemia and inflammation. Curr Opin Crit Care 18: 178-185, 2012
60. Kong T, Westerman KA, Faigle M, Eltzschig HK, Colgan SP: HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J 20: 2242-2250, 2006 (Pubitemid 44953854)
61. Liu E, Morimoto M, Kitajima S, Koike T, Yu Y, Shiiki H, Nagata M, Watanabe T, Fan J: Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions. J Am Soc Nephrol 18: 2094-2104, 2007 (Pubitemid 47041075)
62. Cardenas A, Toledo C, Oyarzun C, Sepulveda A, Quezada C, Guillen-Gomez E, Diaz-Encarnacion MM, Pastor-Anglada M, San Martin R: Adenosine a(2b) receptor-mediated vegf induction promotes diabetic glomerulopathy. Lab Invest 93: 135-144, 2013
63. Valladares D, Quezada C, Montecinos P, Concha II, Yañez AJ, Sobrevia L, San Martín R: Adenosine A(2B) receptor mediates an increase on VEGF-A production in rat kidney glomeruli. Biochem Biophys Res Commun 366: 180-185, 2008
64. Foster RR: The importance of cellular VEGF bioactivity in the development of glomerular disease. Nephron, Exp Nephrol 113: e8-e15, 2009
65. + regulatory T cells contribute to adenosine-mediated resolution of acute lung injury. FASEB J 27: 2207-2019, 2013
66. Ehrentraut H, Westrich JA, Eltzschig HK, Clambey ET: Adora2b adenosine receptor engagement enhances regulatory T cell abundance during endotoxin-induced pulmonary inflammation. PLoS ONE 7: e32416, 2012
67. Homann D, von Herrath M: Regulatory T cells and type 1 diabetes. Clin Immunol 112: 202-209, 2004 (Pubitemid 39078692)
68. Breyer MD, Böttinger E, Brosius FC 3rd, Coffman TM, Harris RC, Heilig CW, Sharma K; AMDCC: Mouse models of diabetic nephropathy. J Am Soc Nephrol 16: 27-45, 2005 (Pubitemid 43073154)
69. Quaggin SE, Coffman TM: Toward a mouse model of diabetic nephropathy: is endothelial nitric oxide synthase the missing link? J Am Soc Nephrol 18: 364-366, 2007 (Pubitemid 46193298)
70. Beitner-Johnson D, Shull GE, Dedman JR, Millhorn DE: Regulation of gene expression by hypoxia: Amolecular approach. Respir Physiol 110: 87-97, 1997 (Pubitemid 27505177)
71. Wang J, Takeuchi T, Tanaka S, Kubo SK, Kayo T, Lu D, Takata K, Koizumi A, Izumi T: A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J Clin Invest 103: 27-37, 1999 (Pubitemid 29031160)
72. Oyadomari S, Koizumi A, Takeda K, Gotoh T, Akira S, Araki E, Mori M: Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. J Clin Invest 109: 525-532, 2002 (Pubitemid 34171784)
73. Sharma K, McCue P, Dunn SR: Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol 284: F1138-F1144, 2003 (Pubitemid 36578440)
74. Chow FY, Nikolic-Paterson DJ, Atkins RC, Tesch GH. Macrophages in streptozotocin-induced diabetic nephropathy: Potential role in renal fibrosis. Nephrol Dial Transplant 19: 2987-2996, 2004 (Pubitemid 40057619)
75. Nakagawa T, Sato W, Glushakova O, Heinig M, Clarke T, Campbell-Thompson M, Yuzawa Y, Atkinson MA, Johnson RJ, Croker B: Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol 18: 539-550, 2007 (Pubitemid 46193319)
76. Dai HY, Zheng M, Lv LL, Tang RN, Ma KL, Liu D, Wu M, Liu BC: The roles of connective tissue growth factor and integrin-linked kinase in high glucose-induced phenotypic alterations of podocytes. J Cell Biochem 113: 293-301, 2012
77. Calkin AC, Giunti S, Jandeleit-Dahm KA, Allen TJ, Cooper ME, Thomas MC: Ppar-alpha and -gamma agonists attenuate diabetic kidney disease in the apolipoprotein e knockout mouse. Nephrol Dial Transplant 21: 2399-2405, 2006 (Pubitemid 44644510)
78. Kosugi T, Nakayama T, Heinig M, Zhang L, Yuzawa Y, Sanchez-Lozada LG, Roncal C, Johnson RJ, Nakagawa T: Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice. Am J Physiol Renal Physiol 297: F481-F488, 2009